BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  SOTIO Completes Enrollment of Phase III VIABLE Study in Late Stage Prostate Cancer

  The VIABLE study is a randomized, double blind, multicenter, parallel-group Phase III study to evaluate the efficacy and safety of DCVAC/PCa as an add-on therapy to first-line standard of care chemotherapy in men with mCRPC.

  November 6, 2017

   · 

  3 min read
• Business

  Supervisory Board of Epigenomics AG Appoints Dr. Jorge Garces as President and CSO

  Dr. Garces will become a member of the Executive Board of Epigenomics and oversee Operations, Research and Development, Clinical Affairs, Regulatory and Quality.

  November 6, 2017

   · 

  3 min read
• Business

  Collaboration Project Agreement Between MAB Discovery GmbH And BioNTech AG

  Financial terms of the agreement were not disclosed.

  November 6, 2017

   · 

  2 min read
• Drug Development

  New Data From Long-Term Extension of Phase 1B Study of Investigational Alzheimer’s Disease Treatment Aducanumab Presented at 10th Clinical Trials on ALZ’s Disease

  As of October 23, 2017, Eisai and Biogen entered into a global collaboration agreement to jointly develop and commercialize aducanumab.

  November 6, 2017

   · 

  4 min read
• Business

  Softbox Systems Opens New Manufacturing Site In Continental Europe

  Softbox Systems today announces the opening of a new manufacturing site in The Netherlands, in partnership with Kingspan Unidek.

  November 6, 2017

   · 

  1 min read
• FDA

  Medtronic Wins CE Mark for the World’s Smallest Fully Implantable Spinal Cord Stimulator

  The Intellis platform is managed on the Samsung Galaxy Tab S2 tablet interface and can record and track patient activity 24/7.

  November 6, 2017

   · 

  7 min read
• Drug Development

  Advicenne Announces Positive 6-Month Extension Study Data from Pivotal Phase III Study of ADV7103 in Adults and Children Suffering From Distal Renal Tubular Acidosis (dRTA)

  The extension study followed the pivotal phase III trial, which showed ADV7103’s ability to restore the main biological defects observed with the disease, meeting primary and secondary endpoints.

  November 6, 2017

   · 

  5 min read
• GenSight Biologics to Participate in Multiple Conferences in November

  GenSight Biologics today announced that members of its management team will participate in the following industry, medical and investor conferences: OIS, AAO, and Stifel Healthcare Conferences.

  November 6, 2017

   · 

  2 min read
• Business

  Mesa Labs Reports Second Quarter Results

  The company reported its results for the second quarter ended September 30, 2017.

  November 6, 2017

   · 

  11 min read
• Drug Development

  Bio-Path Holdings Highlights Advancements in Preclinical Discovery Efforts

  The company selected its third drug candidate, BP1003, for the treatment of pancreatic cancer and provided an update on several of its preclinical discovery efforts.

  November 6, 2017

   · 

  2 min read